|4Dec 12, 5:17 PM ET

Roivant Sciences Ltd. 4

4 · Immunovant, Inc. · Filed Dec 12, 2025

Insider Transaction Report

Form 4
Period: 2025-12-12
Roivant Sciences Ltd.
Director10% Owner
Transactions
  • Purchase

    Common Stock, $0.0001 par value per share

    2025-12-12$21.00/sh+16,666,666$349,999,986113,317,007 total

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4